Folate Biomarkers, Folate Intake, and Risk of Death From All Causes, Cardiovascular Disease, and Cancer: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies

Existing evidence on the relation between folate intake and biomarkers with mortality risk is controversial. Previous cohort studies were examined regarding folate intake and biomarkers in relation to risk of all-cause, cardiovascular disease- (CVD), and cancer-related mortality through a systematic...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nutrition reviews 2024-07
Hauptverfasser: Fallah, Melika, Karim Dehnavi, Maryam, Lotfi, Keyhan, Aminianfar, Azadeh, Azadbakht, Leila, Esmaillzadeh, Ahmad
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title Nutrition reviews
container_volume
creator Fallah, Melika
Karim Dehnavi, Maryam
Lotfi, Keyhan
Aminianfar, Azadeh
Azadbakht, Leila
Esmaillzadeh, Ahmad
description Existing evidence on the relation between folate intake and biomarkers with mortality risk is controversial. Previous cohort studies were examined regarding folate intake and biomarkers in relation to risk of all-cause, cardiovascular disease- (CVD), and cancer-related mortality through a systematic review and meta-analysis. A systematic search was performed of the PubMed, Scopus, and ISI Web of Science databases up to July 2023. Prospective cohort studies examining the association of folate biomarkers (in serum, plasma, red blood cells) and intake with risk of all-cause, CVD-, and cancer-related mortality were considered. A random-effects model was applied to combine study-specific risk estimates. Dose-response relations were assessed by 1-stage weighted mixed-effects meta-analysis. A total of 25 cohorts with 423 304 participants, 36 558 all-cause, 12 662 CVD-, and 2426 cancer-related deaths were included. No significant association was observed between the highest levels of folate biomarkers and all-cause mortality risk (hazard ratio [HR], 0.91; 95% CI, 0.77-1.06; n = 17; I2 = 89.4%; P 
doi_str_mv 10.1093/nutrit/nuae077
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3074726240</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3074726240</sourcerecordid><originalsourceid>FETCH-LOGICAL-c180t-6b286574dd1b40be3aa52b5df787f0ff92ce79af61d51255542a64d02b1d2d3</originalsourceid><addsrcrecordid>eNo9kU-P00AMxUcIxJaFK0c0Rw6bZf4kmYRbSSmstAjUco-cjKMdmmTKeFLUr8anI0sDJ0v2e8-Wf4y9luJWilK_G6cYXJwLoDDmCVtJk-kkLQrzlK2EUGWS56m-Yi-IfgghpCr1c3alizITqcxX7PfW9xCRf3B-gHDAQDd8ad2NEQ54w2G0fOfowH3HNwjxgW-DH_i673kFE-HsqCBY509A7dRD4BtHCLRYKxhbDO_5mu_PFHGA6Fq-w5PDX3_nG0-Y7JCOfiTkXzBCsh6hP5Ojx43fgqcjttGdkFf-wYfI93GyDukle9ZBT_hqqddsv_34vfqc3H_9dFet75NWFiImeaOKPDOptbJJRYMaIFNNZjtTmE50XalaNCV0ubSZVFmWpQry1ArVSKusvmZvL6nH4H9OSLEeHLXY9zCin6jWwqRG5SoVs_T2Im3nmylgVx-Dm796rqWoH2nVF1r1Qms2vFmyp2ZA-1_-D4_-AwlulS8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3074726240</pqid></control><display><type>article</type><title>Folate Biomarkers, Folate Intake, and Risk of Death From All Causes, Cardiovascular Disease, and Cancer: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies</title><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Fallah, Melika ; Karim Dehnavi, Maryam ; Lotfi, Keyhan ; Aminianfar, Azadeh ; Azadbakht, Leila ; Esmaillzadeh, Ahmad</creator><creatorcontrib>Fallah, Melika ; Karim Dehnavi, Maryam ; Lotfi, Keyhan ; Aminianfar, Azadeh ; Azadbakht, Leila ; Esmaillzadeh, Ahmad</creatorcontrib><description>Existing evidence on the relation between folate intake and biomarkers with mortality risk is controversial. Previous cohort studies were examined regarding folate intake and biomarkers in relation to risk of all-cause, cardiovascular disease- (CVD), and cancer-related mortality through a systematic review and meta-analysis. A systematic search was performed of the PubMed, Scopus, and ISI Web of Science databases up to July 2023. Prospective cohort studies examining the association of folate biomarkers (in serum, plasma, red blood cells) and intake with risk of all-cause, CVD-, and cancer-related mortality were considered. A random-effects model was applied to combine study-specific risk estimates. Dose-response relations were assessed by 1-stage weighted mixed-effects meta-analysis. A total of 25 cohorts with 423 304 participants, 36 558 all-cause, 12 662 CVD-, and 2426 cancer-related deaths were included. No significant association was observed between the highest levels of folate biomarkers and all-cause mortality risk (hazard ratio [HR], 0.91; 95% CI, 0.77-1.06; n = 17; I2 = 89.4%; P &lt; .001), CVD-related mortality risk (HR, 0.97; 95% CI, 0.87-1.06; n = 11; I2 = 0.0%; P = .57), and cancer-related mortality risk (HR, 0.85; 95% CI, 0.69-1.05; n = 6; I2 = 57.8%; P = .04) compared with the lowest. Furthermore, each 10 nmol/L increase was marginally related to a 12% reduced all-cause mortality risk but not to CVD- and cancer-related mortality risk. A significant inverse association was found between highest intake of dietary folate and the lowest, and risk of all-cause (HR, 0.87; 95% CI, 0.78-0.96; n = 3; I2 = 63.6%; P = .06) and CVD (HR, 0.77; 95% CI, 0.57-0.93; n = 4; I2 = 80.2%; P = .002) mortality. This meta-analysis revealed a significant inverse relation between dietary folate intake and risk of all-cause and CVD mortality. Such an association was not found in the case of folate biomarkers. Further prospective studies are warranted to confirm these findings. PROSPERO registration no. CRD42023401700.</description><identifier>ISSN: 0029-6643</identifier><identifier>ISSN: 1753-4887</identifier><identifier>EISSN: 1753-4887</identifier><identifier>DOI: 10.1093/nutrit/nuae077</identifier><identifier>PMID: 38950416</identifier><language>eng</language><publisher>United States</publisher><ispartof>Nutrition reviews, 2024-07</ispartof><rights>The Author(s) 2024. Published by Oxford University Press on behalf of the International Life Sciences Institute. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c180t-6b286574dd1b40be3aa52b5df787f0ff92ce79af61d51255542a64d02b1d2d3</cites><orcidid>0000-0001-6139-9578 ; 0000-0002-0490-8492</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38950416$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fallah, Melika</creatorcontrib><creatorcontrib>Karim Dehnavi, Maryam</creatorcontrib><creatorcontrib>Lotfi, Keyhan</creatorcontrib><creatorcontrib>Aminianfar, Azadeh</creatorcontrib><creatorcontrib>Azadbakht, Leila</creatorcontrib><creatorcontrib>Esmaillzadeh, Ahmad</creatorcontrib><title>Folate Biomarkers, Folate Intake, and Risk of Death From All Causes, Cardiovascular Disease, and Cancer: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies</title><title>Nutrition reviews</title><addtitle>Nutr Rev</addtitle><description>Existing evidence on the relation between folate intake and biomarkers with mortality risk is controversial. Previous cohort studies were examined regarding folate intake and biomarkers in relation to risk of all-cause, cardiovascular disease- (CVD), and cancer-related mortality through a systematic review and meta-analysis. A systematic search was performed of the PubMed, Scopus, and ISI Web of Science databases up to July 2023. Prospective cohort studies examining the association of folate biomarkers (in serum, plasma, red blood cells) and intake with risk of all-cause, CVD-, and cancer-related mortality were considered. A random-effects model was applied to combine study-specific risk estimates. Dose-response relations were assessed by 1-stage weighted mixed-effects meta-analysis. A total of 25 cohorts with 423 304 participants, 36 558 all-cause, 12 662 CVD-, and 2426 cancer-related deaths were included. No significant association was observed between the highest levels of folate biomarkers and all-cause mortality risk (hazard ratio [HR], 0.91; 95% CI, 0.77-1.06; n = 17; I2 = 89.4%; P &lt; .001), CVD-related mortality risk (HR, 0.97; 95% CI, 0.87-1.06; n = 11; I2 = 0.0%; P = .57), and cancer-related mortality risk (HR, 0.85; 95% CI, 0.69-1.05; n = 6; I2 = 57.8%; P = .04) compared with the lowest. Furthermore, each 10 nmol/L increase was marginally related to a 12% reduced all-cause mortality risk but not to CVD- and cancer-related mortality risk. A significant inverse association was found between highest intake of dietary folate and the lowest, and risk of all-cause (HR, 0.87; 95% CI, 0.78-0.96; n = 3; I2 = 63.6%; P = .06) and CVD (HR, 0.77; 95% CI, 0.57-0.93; n = 4; I2 = 80.2%; P = .002) mortality. This meta-analysis revealed a significant inverse relation between dietary folate intake and risk of all-cause and CVD mortality. Such an association was not found in the case of folate biomarkers. Further prospective studies are warranted to confirm these findings. PROSPERO registration no. CRD42023401700.</description><issn>0029-6643</issn><issn>1753-4887</issn><issn>1753-4887</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNo9kU-P00AMxUcIxJaFK0c0Rw6bZf4kmYRbSSmstAjUco-cjKMdmmTKeFLUr8anI0sDJ0v2e8-Wf4y9luJWilK_G6cYXJwLoDDmCVtJk-kkLQrzlK2EUGWS56m-Yi-IfgghpCr1c3alizITqcxX7PfW9xCRf3B-gHDAQDd8ad2NEQ54w2G0fOfowH3HNwjxgW-DH_i673kFE-HsqCBY509A7dRD4BtHCLRYKxhbDO_5mu_PFHGA6Fq-w5PDX3_nG0-Y7JCOfiTkXzBCsh6hP5Ojx43fgqcjttGdkFf-wYfI93GyDukle9ZBT_hqqddsv_34vfqc3H_9dFet75NWFiImeaOKPDOptbJJRYMaIFNNZjtTmE50XalaNCV0ubSZVFmWpQry1ArVSKusvmZvL6nH4H9OSLEeHLXY9zCin6jWwqRG5SoVs_T2Im3nmylgVx-Dm796rqWoH2nVF1r1Qms2vFmyp2ZA-1_-D4_-AwlulS8</recordid><startdate>20240701</startdate><enddate>20240701</enddate><creator>Fallah, Melika</creator><creator>Karim Dehnavi, Maryam</creator><creator>Lotfi, Keyhan</creator><creator>Aminianfar, Azadeh</creator><creator>Azadbakht, Leila</creator><creator>Esmaillzadeh, Ahmad</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-6139-9578</orcidid><orcidid>https://orcid.org/0000-0002-0490-8492</orcidid></search><sort><creationdate>20240701</creationdate><title>Folate Biomarkers, Folate Intake, and Risk of Death From All Causes, Cardiovascular Disease, and Cancer: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies</title><author>Fallah, Melika ; Karim Dehnavi, Maryam ; Lotfi, Keyhan ; Aminianfar, Azadeh ; Azadbakht, Leila ; Esmaillzadeh, Ahmad</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c180t-6b286574dd1b40be3aa52b5df787f0ff92ce79af61d51255542a64d02b1d2d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fallah, Melika</creatorcontrib><creatorcontrib>Karim Dehnavi, Maryam</creatorcontrib><creatorcontrib>Lotfi, Keyhan</creatorcontrib><creatorcontrib>Aminianfar, Azadeh</creatorcontrib><creatorcontrib>Azadbakht, Leila</creatorcontrib><creatorcontrib>Esmaillzadeh, Ahmad</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Nutrition reviews</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fallah, Melika</au><au>Karim Dehnavi, Maryam</au><au>Lotfi, Keyhan</au><au>Aminianfar, Azadeh</au><au>Azadbakht, Leila</au><au>Esmaillzadeh, Ahmad</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Folate Biomarkers, Folate Intake, and Risk of Death From All Causes, Cardiovascular Disease, and Cancer: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies</atitle><jtitle>Nutrition reviews</jtitle><addtitle>Nutr Rev</addtitle><date>2024-07-01</date><risdate>2024</risdate><issn>0029-6643</issn><issn>1753-4887</issn><eissn>1753-4887</eissn><abstract>Existing evidence on the relation between folate intake and biomarkers with mortality risk is controversial. Previous cohort studies were examined regarding folate intake and biomarkers in relation to risk of all-cause, cardiovascular disease- (CVD), and cancer-related mortality through a systematic review and meta-analysis. A systematic search was performed of the PubMed, Scopus, and ISI Web of Science databases up to July 2023. Prospective cohort studies examining the association of folate biomarkers (in serum, plasma, red blood cells) and intake with risk of all-cause, CVD-, and cancer-related mortality were considered. A random-effects model was applied to combine study-specific risk estimates. Dose-response relations were assessed by 1-stage weighted mixed-effects meta-analysis. A total of 25 cohorts with 423 304 participants, 36 558 all-cause, 12 662 CVD-, and 2426 cancer-related deaths were included. No significant association was observed between the highest levels of folate biomarkers and all-cause mortality risk (hazard ratio [HR], 0.91; 95% CI, 0.77-1.06; n = 17; I2 = 89.4%; P &lt; .001), CVD-related mortality risk (HR, 0.97; 95% CI, 0.87-1.06; n = 11; I2 = 0.0%; P = .57), and cancer-related mortality risk (HR, 0.85; 95% CI, 0.69-1.05; n = 6; I2 = 57.8%; P = .04) compared with the lowest. Furthermore, each 10 nmol/L increase was marginally related to a 12% reduced all-cause mortality risk but not to CVD- and cancer-related mortality risk. A significant inverse association was found between highest intake of dietary folate and the lowest, and risk of all-cause (HR, 0.87; 95% CI, 0.78-0.96; n = 3; I2 = 63.6%; P = .06) and CVD (HR, 0.77; 95% CI, 0.57-0.93; n = 4; I2 = 80.2%; P = .002) mortality. This meta-analysis revealed a significant inverse relation between dietary folate intake and risk of all-cause and CVD mortality. Such an association was not found in the case of folate biomarkers. Further prospective studies are warranted to confirm these findings. PROSPERO registration no. CRD42023401700.</abstract><cop>United States</cop><pmid>38950416</pmid><doi>10.1093/nutrit/nuae077</doi><orcidid>https://orcid.org/0000-0001-6139-9578</orcidid><orcidid>https://orcid.org/0000-0002-0490-8492</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0029-6643
ispartof Nutrition reviews, 2024-07
issn 0029-6643
1753-4887
1753-4887
language eng
recordid cdi_proquest_miscellaneous_3074726240
source Oxford University Press Journals All Titles (1996-Current)
title Folate Biomarkers, Folate Intake, and Risk of Death From All Causes, Cardiovascular Disease, and Cancer: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T20%3A32%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Folate%20Biomarkers,%20Folate%20Intake,%20and%20Risk%20of%20Death%20From%20All%20Causes,%20Cardiovascular%20Disease,%20and%20Cancer:%20A%20Systematic%20Review%20and%20Dose-Response%20Meta-Analysis%20of%20Prospective%20Cohort%20Studies&rft.jtitle=Nutrition%20reviews&rft.au=Fallah,%20Melika&rft.date=2024-07-01&rft.issn=0029-6643&rft.eissn=1753-4887&rft_id=info:doi/10.1093/nutrit/nuae077&rft_dat=%3Cproquest_cross%3E3074726240%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3074726240&rft_id=info:pmid/38950416&rfr_iscdi=true